Home›Stock Screener›Emmessar Biotech

Emmessar Biotech Share Price Today | Stock Price & Emmessar Biotech Share Screener

EMMESSA Chemicals & Petrochemicals
Live Share Price BSE
₹27.60
▼ -0.79 (-2.78%)
2026-11-18 00:00:00

As of November 18, 2026, the live Emmessar Biotech share price (BSE: EMMESSA) is ₹27.60, down 2.78% from the previous close, with shares trading between ₹27.60 and ₹28.80 in today's trading session, and a 52-week range of ₹19.99–₹32.35. Track Emmessar Biotech networth to gauge the company's total market size. Use the Emmessar Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Emmessar Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Emmessar Biotech Market Cap ₹13.00 Cr.
EMMESSA P/E Ratio (TTM) 30.90
Emmessar Biotech P/B Ratio 1.55
EPS (TTM) ₹0.87
Dividend Yield -
Debt to Equity -
EMMESSA 52 Week High ₹32.35
Emmessar Biotech 52 Week Low ₹19.99
Operating Margin -416.00%
Profit Margin -
EMMESSA Revenue (TTM) ₹2.00
EBITDA ₹1.00
Net Income -
Total Assets ₹10.00
Total Equity ₹8.00

Emmessar Biotech Share Price Chart

Track the current stock price of Emmessar Biotech with an interactive chart. Analyse EMMESSA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Emmessar Biotech stock quote in one place.

The quote of ₹27.60 sits between the 52-week low of ₹19.99 and the 52-week high of ₹32.35, and the latest session moved -2.78% from the previous close.

Emmessar Biotech Company Profile - Fundamental Screener

Screen Emmessar Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EMMESSA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Chemicals & Petrochemicals industry, and it trades under ISIN INE634B01016.

Company Details

Classification

Sector Chemicals
Industry Chemicals & Petrochemicals
Sub-Sector Chemicals & Petrochemicals
Segment E

Identifiers and Leadership

ISIN INE634B01016

Emmessar Biotech Balance Sheet Screener

Screen EMMESSA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹10, up from ₹9 in 2025.

Latest statistics put total assets at ₹10 and shareholder funds at ₹8.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 10 9 9 8 7 8 6 5 4 3
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 2 2 2 2 2 2 2 2 2 1

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 1 1 1 1 1 1 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 8 8 7 7 6 6 4 4 3 2
Share Capital 5 5 5 5 5 5 5 5 5 5
Reserves & Surplus 3 3 2 2 1 1 -1 -2 -2 -3

Emmessar Biotech Income Statement Screener - Profit & Revenue Analysis

Screen Emmessar Biotech income statement and profit fundamentals. Analyze EMMESSA quarterly results. Emmessar Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹2 and net profit was ₹0, equal to earnings per unit of ₹0.80, at an operating margin of -416%.

In that period expenses were ₹2, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹2 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 2 2 3 3 3 2 9 5 2 3 4 2 2
Expenses 2 2 2 2 2 1 6 4 1 2 2 2 2

Operating Costs and Margins

EBITDA 1 1 1 1 1 1 2 1 1 1 1 0 0
Operating Profit % -416.00% -365.00% -156.00% -195.00% -68.00% -245.00% 12.00% -12.00% -102.00% -32.00% 9.00% 1.00% -7.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 1 1 1 1 1 1 2 1 0 1 1 -1 0
Tax 0 0 1 0 1 1 1 0 0 0 0 0 0
Net Profit 0 0 0 1 1 1 1 1 1 1 1 -1 0
EPS 0.80 0.87 0.63 1.50 0.99 0.94 2.90 1.51 1.05 1.83 2.36 -0.93 -0.24

Emmessar Biotech Cash Flow Screener - Liquidity Fundamentals

Screen EMMESSA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0.

Over the same period, investing activities provided ₹0 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 0 0 1 0 2 1 1 0 1 1
Investing Activities 0 0 -1 -1 -3 0 -1 0 -1 -1

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 0 0 1 0 0 0 0

Emmessar Biotech Shareholding Pattern Screener

See Emmessar Biotech shareholding pattern with promoter, FII, and DII holdings. Check Emmessar Biotech promoter holding and ownership changes for EMMESSA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 59.53%, foreign institutions 0.00%, domestic institutions 0.20% and the public 38.07%, spread across 7,172 shareholders.

The shareholder count was 7,172 in 2026-Mar, compared with 7,136 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 38.07% 38.07% 38.07% 37.15% 37.14% 38.12% 38.09% 37.94%
Other Holding 2.21% 2.21% 2.21% 3.12% 3.14% 2.16% 2.19% 2.33%
Shareholder Count 7,172 7,136 7,144 7,180 7,173 7,350 7,244 7,146

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Emmessar Biotech. Emmessar Biotech dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Emmessar Biotech.

Emmessar Biotech Stock Index Membership - Nifty & Sensex

See which indices include Emmessar Biotech stock. Check EMMESSA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Emmessar Biotech is not part of any tracked indices.
Only major market indices are tracked in our system.

Emmessar Biotech Market Events Screener - Corporate Actions

Get Emmessar Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Emmessar Biotech stock events that may affect EMMESSA share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 31, 2026, with a record date of October 31, 2026.

It is followed by Annual General Meeting dated September 29, 2026 and Quarterly Result Announcement dated August 7, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-31 2026-10-31 Quarterly Result Announcement NA 5.87%
2026-09-29 2026-09-29 Annual General Meeting NA -10.83%
2026-08-07 2026-08-07 Quarterly Result Announcement NA 0.24%
2026-05-12 2026-05-12 Quarterly Result Announcement NA 2.94%
2026-02-11 2026-02-11 Quarterly Result Announcement NA 2.14%
2025-11-12 2025-11-12 Quarterly Result Announcement NA 0.36%
2025-09-26 2025-09-26 Annual General Meeting NA 23.37%
2025-08-07 2025-08-07 Quarterly Result Announcement NA -4.34%
2025-04-24 2025-04-24 Quarterly Result Announcement NA 6.06%
2025-02-06 2025-02-06 Quarterly Result Announcement NA 7.24%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 43.67%
2024-09-27 2024-09-27 Annual General Meeting NA 7.42%

Emmessar Biotech Competitors Screener - Peer Stocks Comparison

Screen EMMESSA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Solar Industries 174,990 74.20 9,966 30.94% 1,737 50.71
Pidilite Industries 155,298 57.30 14,867 11.05% 2,471 50.46
SRF 73,365 32.10 15,894 7.20% 1,835 53.97
Linde 58,424 118.20 2,549 -0.17% 549 69.72
Gujarat Fluorochemicals 51,762 78.30 5,126 5.63% 574 58.93
Navin Fluorine International 51,303 56.50 3,379 41.21% 664 75.55
Aether Industries 22,261 89.20 1,181 34.17% 220 58.26
Deepak Nitrite 21,747 20.50 7,947 -5.01% 551 55.38
Aarti Industries 17,475 29.50 8,291 13.78% 419 59.07
Fine Organic Industries 16,248 33.80 2,483 4.89% 417 54.16

Emmessar Biotech Company Announcements - News & Reports Screener

Screen EMMESSA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 2, 2026.

The next most recent announcements are dated October 31, 2026 and October 31, 2026.

Date Update Actions
2026-11-02 Newspaper Add -
2026-10-31 Financial Results For 30Th September 2026. -
2026-10-31 Board Meeting Outcome for For Unaudited Financial Results For Period Ending 30/09/2026 -
2026-10-23 Board Meeting Intimation for Unaudited Results For The Quarter Ended September 30 2026 -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-02 Newapaper Add For Relodgment Of Shares -
2026-09-29 Closure of Trading Window -
2026-09-29 Scutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-05 Newspaper Add -
2026-09-04 Communication To Shareholders Whose Email Ids Are Not Registered -
2026-09-04 Communication Sent To Shareholders Holding Physical Shares -
2026-09-04 Reg. 34 (1) Annual Report. -
2026-09-04 Notice Of The 34Th Annnual General Meeting Of The Company To Be Held On September 29 2026 -
2026-08-27 Newspaper Add For AGM -
2026-08-08 Newapaper Add -
2026-08-07 Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-08-07 Board Meeting Outcome for For Unaudited Financial Results For The Quarter Ending June 30 2026 -
2026-08-01 Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-08-01 Newspaper Add For Relodgement Of Shares -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹27.60, within a 52-week range of ₹19.99 to ₹32.35. The P/E ratio is 30.90 and the P/B ratio is 1.55, with earnings per unit of ₹0.87. Market capitalisation stands at ₹13.00 Cr. The company operates in the Chemicals sector, in the Chemicals & Petrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.